Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Infect Disord Drug Targets ; 13(2): 133-40, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23808873

RESUMO

This paper presents unequivocal results about the presence of trypanothione and its precursor glutathionespermidine from the opportunistic human pathogen Acanthamoeba polyphaga. They were isolated by RP-HPLC as thiolbimane derivatives and characterized using matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF/TOF). Additionally RP-HPLC demonstrated that thiol-bimane compounds corresponding to cysteine and glutathione were also present in A. polyphaga. Besides trypanothione, we want to report four new peptides in trophozoites, a tetrapeptide, a hexapeptide, a heptapeptide and a nonapeptide. Trypanothione and two of the thiol peptides, the hexapeptide and heptapeptide, are oxidized since the reduced forms increase in amount when the normal extract is treated by DTT or by electrolytic reduction that convert the oxidized forms to reduced ones. On the other hand, they disappear when the amoeba extract is treated with NEM or when the amoeba culture is treated with various inhibitors of NADPH-dependent disulfidereducing enzymes. Comparison of the thiol peptides, including trypanothione from A. polyphaga with extracts from human lymphocytes showed that they are not present in the latter. Therefore, some of the peptides here reported could be used as antigens for rapid detection of these parasites. In regard to the presence of the enzymes that synthesize and reduce trypanothione in A. polyphaga we suggest that they can be used as drug targets.


Assuntos
Acanthamoeba/química , Acanthamoeba/metabolismo , Glutationa/análogos & derivados , Peptídeos/química , Proteínas de Protozoários/química , Espermidina/análogos & derivados , Cromatografia Líquida de Alta Pressão/métodos , Glutationa/química , Glutationa/isolamento & purificação , Glutationa/metabolismo , Humanos , Peptídeos/isolamento & purificação , Peptídeos/metabolismo , Proteínas de Protozoários/isolamento & purificação , Proteínas de Protozoários/metabolismo , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Espermidina/química , Espermidina/isolamento & purificação , Espermidina/metabolismo
2.
Recent Pat Antiinfect Drug Discov ; 2(3): 206-16, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18221178

RESUMO

This paper reviews the inhibition of various enzymes by neuroleptics, anti-mycotics, antibiotics and other drugs on three species of human pathogenic amoebas, mainly Entamoeba histolytica, Acanthamoeba polyphaga and Naegleria fowleri, and their antiproliferative effects. A recent patent registered by Philip relates to the combination of an antibacterial formulation and antifungal agent for producing a therapeutically effective quantity of an antimicrobial that is suitable for suppressing or treating fungal growth. The rationale behind this patent focused on essential and valid targets with a description of the main pathogenic characteristics of these amoebas. The study of new targets, such as trypanothione and trypanothione reductase, and the drug effects of selected agents were arranged into six main groups: A) Inhibition of disulfide reducing enzymes by neuroleptics, antimycotics and antibiotics; B) Comparative evaluation of the efficacies of several drugs with antiproliferative activities; C) Inhibition of the enzymes for the synthesis of trypanothione, such as ornithine decarboxylase, spermidine synthase and trypanothione synthetase; D) Inhibition of the glycolytic enzyme PPi-dependent phosphofructokinase (PFK) from Entamoeba and Naegleria by pyrophosphate analogues, different from the host enzyme; E) Inhibition of enzymes secreted by these parasites to invade the human host, for example cysteine proteinases; and F) Inhibition of encystment pathways and cyst-wall assembly proteins.


Assuntos
Amebíase/tratamento farmacológico , Amoeba/efeitos dos fármacos , Antibacterianos/farmacologia , Antifúngicos/farmacologia , Antipsicóticos/farmacologia , Inibidores Enzimáticos/farmacologia , Amebíase/parasitologia , Amebíase/patologia , Amoeba/crescimento & desenvolvimento , Animais , Divisão Celular/efeitos dos fármacos , Inibidores de Cisteína Proteinase/farmacologia , Inibidores de Cisteína Proteinase/uso terapêutico , Dissulfetos/metabolismo , Inibidores Enzimáticos/uso terapêutico , Glutationa/análogos & derivados , Glutationa/biossíntese , Humanos , Patentes como Assunto , Fosfofrutoquinases/antagonistas & inibidores , Espermidina/análogos & derivados , Espermidina/biossíntese
3.
Exp Parasitol ; 115(1): 41-7, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16806188

RESUMO

This paper discusses the effects of two neuroleptic agents, chlorpromazine and trifluoperazine; three antimycotics, amphotericin B, ketoconazole and miconazole and four antibiotics, pentamidine, rifampicin, mepacrine and metronidazole on the NADPH-dependent disulfide reducing enzymes cystine reductase (CysR), glutathione reductase (GR) trypanothione reductase (TR) and a putative disulfide reductase for compound X in Acanthamoeba polyphaga from the human pathogens A. polyphaga and Naegleria fowleri. Against A. polyphaga, all nine drugs studied had the capacity to inhibit the putative disulfide reductase from the trophozoites at a concentration of 32microg/ml during a 24h incubation and they were: the neuroleptics trifluoperazine (100%) and chlorpromazine (96%), the antimycotics miconazole (89%) ketoconazole (81%) and amphotericin B, (53%) and the antibiotics pentamidine (89%), rifampicin (64%), mepacrine (57%) and metronidazole (14%). Only six of the nine drugs simultaneously inhibited CysR, GR and the putative disulfide reductase. In N. fowleri, the most potent inhibitors of trypanothione reductase were amphotericin B and miconazole which inhibited 100% at a concentration of 32microg/ml during the 24h incubation followed by the neuroleptics trifluoperazine (92%) and chlorpromazine (80%) and the antibiotic mepacrine (70%). All these also inhibited CysR and GR from the trophozoites other than mepacrine which inhibited only CysR and TR. Ketoconazole, rifampicin (which did not affect CysR), pentamidine and metronidazole had opposite effects since they did not inhibit but increased the amount of the three thiols.


Assuntos
Acanthamoeba/efeitos dos fármacos , Antibacterianos/farmacologia , Antifúngicos/farmacologia , Antipsicóticos/farmacologia , NADH NADPH Oxirredutases/efeitos dos fármacos , Naegleria fowleri/efeitos dos fármacos , Acanthamoeba/enzimologia , Animais , Cromatografia Líquida de Alta Pressão , Glutationa Redutase/efeitos dos fármacos , Glutationa Redutase/metabolismo , Humanos , NADH NADPH Oxirredutases/metabolismo , Naegleria fowleri/enzimologia
4.
Arch Med Res ; 37(6): 723-9, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16824931

RESUMO

BACKGROUND: Using reproducible conditions in vitro, the aim of this study was to obtain a comparative evaluation of the efficacies of several tricyclic neuroleptics, antimycotics and antibiotics with antiproliferative activities against Acanthamoeba polyphaga and Naegleria fowleri trophozoites. METHODS: We used reproducible conditions in vitro to obtain results. RESULTS: In the case of A.polyphaga, the tricyclic neuroleptics trifluoperazine and chlorpromazine had the best inhibitory (IC50) effects followed by mepacrine, ketoconazole, pentamidine, miconazole, amphotericin B, and metronidazole. Of all, rifampicin was the least effective. Mepacrine was the most effective compound with the minimum inhibitory concentration (MIC100) against A.polyphaga [corrected] The most effective drugs against N. fowleri expressed as (IC50) were as follows: the antimycotics ketoconazole and amphotericin B, followed by trifluoperazine, mepacrine, chlorpromazine, miconazole, and metronidazole. The least effectives were rifampicin and pentamidine. The most potent growth inhibitors (MIC100) against N. fowleri were the antimycotics amphotericin B and ketoconazole and the neuroleptic trifluoperazine. It was clear that there are major differences between the two amebas in their susceptibility to some of the drugs. CONCLUSIONS: The drugs with the minimal inhibitory concentration (MIC) values could be considered alone or in combination as potential anti-amebic agents for the treatment of the diseases produced by these amebas.


Assuntos
Acanthamoeba , Antibacterianos/farmacologia , Antifúngicos/farmacologia , Antipsicóticos/farmacologia , Proliferação de Células/efeitos dos fármacos , Naegleria fowleri , Acanthamoeba/efeitos dos fármacos , Acanthamoeba/fisiologia , Animais , Relação Dose-Resposta a Droga , Humanos , Naegleria fowleri/efeitos dos fármacos , Naegleria fowleri/fisiologia
5.
Biotechnol Appl Biochem ; 42(Pt 2): 175-81, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15801913

RESUMO

In this paper, we present definitive data to show, from ESI (electrospray ionization) studies, that the thiol-bimane compound isolated and purified from Entamoeba histolytica trophozoites, corresponds unequivocally to the structure of trypanothione. Trypanothione disulphide was shown to have a molecular ion of m/z 722. It was further demonstrated by MALDI-TOF (matrix-assisted laser desorption ionization-time-of-flight) MS that this thiol compound also corresponds to the characteristic monoprotonated ion of trypanothione-(bimane)(2), which has a molecular ion of m/z 1103.95. The ion pattern of the thiol-bimane compound prepared from the commercial trypanothione standard is identical with the E. histolytica thiol-bimane compound. After HPLC separation, chemical amino acid analysis by dabsylation and dansylation of the thiol bimane compound from Entamoeba showed the presence of the following trypanothione components: glutamic acid, cysteic acid, glycine and spermidine. We can conclude from these highly reliable MS experiments and chemical analyses that E. histolytica contains the thiol compound trypanothione, which was previously thought to occur only in trypanosomatids.


Assuntos
Entamoeba histolytica/química , Glutationa/análogos & derivados , Espectrometria de Massas por Ionização por Electrospray , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Espermidina/análogos & derivados , Animais , Cromatografia Líquida de Alta Pressão , Entamoeba histolytica/patogenicidade , Glutationa/análise , Glutationa/química , Glutationa/isolamento & purificação , Espermidina/análise , Espermidina/química , Espermidina/isolamento & purificação , Compostos de Sulfidrila/química , Compostos de Sulfidrila/isolamento & purificação
6.
Arch Med Res ; 35(5): 378-84, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15610906

RESUMO

BACKGROUND: This study characterizes two long vesicle-associated membrane protein (VAMP) genes (SYBL-1 and SYBL-2) obtained from DNA of Entamoeba histolytica by PCR amplification. (Nucleotide sequences of the Entamoeba histolytica SYBL-1 and SYBL-2 genes appear in the GeneBank under accession numbers AY256852 and AY309014.) METHODS: The two cDNA products include one of 663 bp with sequence of 220 deduced amino acids, and a second of 693 bp with 230 deduced amino acid residues. Both products possess corresponding sequences for longin domain at N-terminus, a soluble N-ethylmaleimide-sensitive factor [NSF] attachment protein receptor (SNARE) coiled-coil region, a transmembrane domain (TM), and an intravesicular tail C-terminal, characteristics of all long VAMPs or longins. The current study identified presence of deduced peptide bonds in SYBL-1 and -2, which indicates that these two long VAMPs from E. histolytica could be appropriate substrates for zinc endopeptidases from tetanus and botulinum neurotoxins with specific activity toward neuronal synaptobrevins. RESULTS: Alignment by Basic Local Alignment Search Tool (BLAST) of deduced amino-acid sequence of long VAMPs genes SYBL-1 and -2 showed identity of between 20 and 40% with Caenorhabditis elegans, Dictyostelium discoideum, Drosophila melanogaster, Arabidopsis thaliana, Mus musculus, Homo sapiens, and Plasmodium falciparum. CONCLUSIONS: It is possible that these two putative transport proteins are involved in endocytosis/exocytosis during a biological membrane fusion process, which may make them suitable candidates as targets for new drugs. According to published data, this is the first time that two such genes have been isolated from E. histolytica.


Assuntos
Entamoeba histolytica/metabolismo , Proteínas de Membrana/metabolismo , Proteínas de Protozoários/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Entamoeba histolytica/genética , Humanos , Proteínas de Membrana/química , Proteínas de Membrana/classificação , Proteínas de Membrana/genética , Dados de Sequência Molecular , Filogenia , Proteínas de Protozoários/química , Proteínas de Protozoários/classificação , Proteínas de Protozoários/genética , Proteínas R-SNARE , Homologia de Sequência de Aminoácidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA